ArticleAAPS PharmSciTech2026
Formulation, Characterization, and Optimization of Ascorbic Acid-Loaded Chitosan Nanoparticles: Investigating the Impact of pH and Ionic Crosslinking Parameters.
Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chitosan nanoparticles are promising carriers for the delivery of labile bioactive compounds, yet the complex interplay between formulation parameters-particularly pH, crosslinker concentration, and drug loading-remains incompletely understood. This study systematically investigated the impact of critical formulation parameters-pH (3, 4, 5), sodium tripolyphosphate (STPP) concentration, and ascorbic acid (AA) loading-on the physicochemical properties of chitosan nanoparticles prepared via ionic gelation. A full factorial design was employed to quantify individual and interactive effects on mean hydrodynamic diameter (MHD), zeta potential (ZP), and entrapment efficiency (%EE). Results demonstrated that pH and STPP concentration were the dominant interacting factors controlling particle size and colloidal stability, while AA loading primarily influenced drug encapsulation. Statistical modeling confirmed a significant pH × STPP interaction for MHD and ZP, whereas AA did not exhibit statistically significant interactive effects on these attributes. However, for entrapment efficiency, significant negative interactions between AA and both pH and STPP revealed a competitive binding mechanism between ascorbate and tripolyphosphate anions. Optimal nanoparticle characteristics-small size (MHD ~ 135-185 nm), high stability (ZP > + 20 mV), and superior drug loading (40-60% EE)-were achieved at pH 3 with moderate STPP levels. A 30-day descriptive stability study further confirmed that pH 3 formulations maintained colloidal integrity. This work provides a data-driven framework for rationally designing chitosan-based nanocarriers, demonstrating that careful control of pH and crosslinker concentration enables tailored particle size and stability, while managing competitive drug-crosslinker interactions is essential for maximizing entrapment efficiency.
Indexed as
Identifiers
42174317What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.